Research Alliance Corp III
Status: Live Deal
U=S
| IPO Proceeds, $M | $75.00M |
|---|---|
| IPO Date | May 20, 2026 |
| CEO | Matthew Hammond, Ph.D. |
| Left Lead | Leerink Partners |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Oak Hill Bio |
| Deal Announced | Jul 27, 2026 |
| Deal Size, $M | $353.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | TBD |
RACC
| Price | $10.02 |
|---|---|
| Last closing price | $10.12 |
| H/L, today | $10.08 / $10.23 |
| Volume, today | 22,887 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.